Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v2.4.0.8
Document And Entity Information
6 Months Ended
Jun. 30, 2014
Aug. 01, 2014
Document Information [Line Items]    
Entity Registrant Name MusclePharm Corp  
Entity Central Index Key 0001415684  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol MSLP  
Entity Common Stock, Shares Outstanding   11,128,440
Document Type 10-Q  
Amendment Flag true  
Document Period End Date Jun. 30, 2014  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2014  
Amendment Description The following is Amendment No. 1 to the Quarterly Report on Form 10-Q for the six months ended June 30, 2014 (the “Form 10-Q”) of MusclePharm Corporation. This Amendment No. 1 is being filed to reflect certain restatements of the Company’s consolidated financial statements for the three months ended June 30, 2014 and for the six months ended June 30, 2014 (see Note 16 of Notes to Consolidated Financial Statements) and to revise certain disclosures and presentations in other parts of the Form 10-Q to be consistent with the restated consolidated financial statements. We also evaluated our consideration on the effectiveness of our internal controls in Item 4. This Amendment amends and supplements Items 1, 2, and 4 of Part I. All other statements and provisions in the Form 10-Q have not been updated and remain unchanged.